206 related articles for article (PubMed ID: 26865505)
1. Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores.
Hu R; Diao J; Li J; Tang Z; Li X; Leitz J; Long J; Liu J; Yu D; Zhao Q
Sci Rep; 2016 Feb; 6():20776. PubMed ID: 26865505
[TBL] [Abstract][Full Text] [Related]
2. Label-free detection of early oligomerization of α-synuclein and its mutants A30P/E46K through solid-state nanopores.
Li X; Tong X; Lu W; Yu D; Diao J; Zhao Q
Nanoscale; 2019 Mar; 11(13):6480-6488. PubMed ID: 30892349
[TBL] [Abstract][Full Text] [Related]
3. N-Terminal Acetylation Preserves α-Synuclein from Oligomerization by Blocking Intermolecular Hydrogen Bonds.
Bu B; Tong X; Li D; Hu Y; He W; Zhao C; Hu R; Li X; Shao Y; Liu C; Zhao Q; Ji B; Diao J
ACS Chem Neurosci; 2017 Oct; 8(10):2145-2151. PubMed ID: 28741930
[TBL] [Abstract][Full Text] [Related]
4. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.
Smith DP; Tew DJ; Hill AF; Bottomley SP; Masters CL; Barnham KJ; Cappai R
Biochemistry; 2008 Feb; 47(5):1425-34. PubMed ID: 18179253
[TBL] [Abstract][Full Text] [Related]
5. Orientation of α-Synuclein at Negatively Charged Lipid Vesicles: Linear Dichroism Reveals Time-Dependent Changes in Helix Binding Mode.
Rocha S; Kumar R; Nordén B; Wittung-Stafshede P
J Am Chem Soc; 2021 Nov; 143(45):18899-18906. PubMed ID: 34748321
[TBL] [Abstract][Full Text] [Related]
6. Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get.
Frey B; AlOkda A; Jackson MP; Riguet N; Duce JA; Lashuel HA
J Neurochem; 2021 May; 157(4):872-888. PubMed ID: 32772367
[TBL] [Abstract][Full Text] [Related]
7. Assembly of α-synuclein aggregates on phospholipid bilayers.
Lv Z; Hashemi M; Banerjee S; Zagorski K; Rochet JC; Lyubchenko YL
Biochim Biophys Acta Proteins Proteom; 2019 Sep; 1867(9):802-812. PubMed ID: 31226488
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein Oligomers Stabilize Pre-Existing Defects in Supported Bilayers and Propagate Membrane Damage in a Fractal-Like Pattern.
Chaudhary H; Iyer A; Subramaniam V; Claessens MM
Langmuir; 2016 Nov; 32(45):11827-11836. PubMed ID: 27766878
[TBL] [Abstract][Full Text] [Related]
9. Single-Molecule Detection of α-Synuclein Oligomers in Parkinson's Disease Patients Using Nanopores.
Liu Y; Wang X; Campolo G; Teng X; Ying L; Edel JB; Ivanov AP
ACS Nano; 2023 Nov; 17(22):22999-23009. PubMed ID: 37947369
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein amyloid oligomers act as multivalent nanoparticles to cause hemifusion in negatively charged vesicles.
Stefanovic AN; Claessens MM; Blum C; Subramaniam V
Small; 2015 May; 11(19):2257-62. PubMed ID: 25641873
[TBL] [Abstract][Full Text] [Related]
11. Probing conformational change of intrinsically disordered α-synuclein to helical structures by distinctive regional interactions with lipid membranes.
Lee SJ; Lee JW; Choi TS; Jin KS; Lee S; Ban C; Kim HI
Anal Chem; 2014 Feb; 86(3):1909-16. PubMed ID: 24383916
[TBL] [Abstract][Full Text] [Related]
12. Two different binding modes of α-synuclein to lipid vesicles depending on its aggregation state.
Högen T; Levin J; Schmidt F; Caruana M; Vassallo N; Kretzschmar H; Bötzel K; Kamp F; Giese A
Biophys J; 2012 Apr; 102(7):1646-55. PubMed ID: 22500765
[TBL] [Abstract][Full Text] [Related]
13. Age- and brain region-dependent α-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains.
Chen M; Yang W; Li X; Li X; Wang P; Yue F; Yang H; Chan P; Yu S
Oncotarget; 2016 Feb; 7(8):8466-80. PubMed ID: 27032368
[TBL] [Abstract][Full Text] [Related]
14. Investigation of α-Synuclein and Amyloid-β(42)-E22Δ Oligomers Using SiN Nanopore Functionalized with L-Dopa.
Abrao-Nemeir I; Bentin J; Meyer N; Janot JM; Torrent J; Picaud F; Balme S
Chem Asian J; 2022 Oct; 17(20):e202200726. PubMed ID: 36038502
[TBL] [Abstract][Full Text] [Related]
15. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.
Brown JW; Buell AK; Michaels TC; Meisl G; Carozza J; Flagmeier P; Vendruscolo M; Knowles TP; Dobson CM; Galvagnion C
Sci Rep; 2016 Nov; 6():36010. PubMed ID: 27808107
[TBL] [Abstract][Full Text] [Related]
16. DIBMA nanodiscs keep α-synuclein folded.
Adão R; Cruz PF; Vaz DC; Fonseca F; Pedersen JN; Ferreira-da-Silva F; Brito RMM; Ramos CHI; Otzen D; Keller S; Bastos M
Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183314. PubMed ID: 32304757
[TBL] [Abstract][Full Text] [Related]
17. Unraveling amyloid formation paths of Parkinson's disease protein α-synuclein triggered by anionic vesicles.
Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S
Q Rev Biophys; 2017 Jan; 50():e3. PubMed ID: 29233215
[TBL] [Abstract][Full Text] [Related]
18. The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding.
Pham CL; Cappai R
Biosci Rep; 2013 Oct; 33(5):. PubMed ID: 24066973
[TBL] [Abstract][Full Text] [Related]
19. Membrane interaction of α-synuclein in different aggregation states.
Grey M; Linse S; Nilsson H; Brundin P; Sparr E
J Parkinsons Dis; 2011; 1(4):359-71. PubMed ID: 23933657
[TBL] [Abstract][Full Text] [Related]
20. Discerning Dynamic Signatures of Membrane-Bound α-Synuclein Using Site-Specific Fluorescence Depolarization Kinetics.
Bhasne K; Jain N; Karnawat R; Arya S; Majumdar A; Singh A; Mukhopadhyay S
J Phys Chem B; 2020 Feb; 124(5):708-717. PubMed ID: 31917569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
